# AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

> **NCT06959524** · NA · RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 1616 (estimated)

## Conditions studied

- Coronary Arterial Disease (CAD)
- de Novo Lesions in Native Coronary Arteries

## Interventions

- **DEVICE:** Drug Eluting Balloon
- **DEVICE:** Drug eluting stent
- **PROCEDURE:** Plain old balloon angioplasty

## Key facts

- **NCT ID:** NCT06959524
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-21
- **Primary completion:** 2028-03
- **Final completion:** 2032-03
- **Target enrollment:** 1616 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06959524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06959524, "AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions". Retrieved via AI Analytics 2026-08-15 from https://api.ai-analytics.org/clinical/NCT06959524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*